Zollinger-Ellison syndrome secondary prevention: Difference between revisions
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of [[gastrinoma]] to prevent malignant trasformation and distant [[metastasis]]. | Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of [[gastrinoma]] to prevent malignant trasformation and distant [[metastasis]]. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Revision as of 14:27, 1 August 2017
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome secondary prevention |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of gastrinoma to prevent malignant trasformation and distant metastasis.
Secondary Prevention
Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of gastrinoma to prevent malignant trasformation and distant metastasis.[1]
References
- ↑ Epelboym I, Mazeh H (2014). "Zollinger-Ellison syndrome: classical considerations and current controversies". Oncologist. 19 (1): 44–50. doi:10.1634/theoncologist.2013-0369. PMC 3903066. PMID 24319020.